Back to Search Start Over

Gilead's Daniel O'Day relishes Dietmar Berger reunion as cancer specialist agrees to join from Sanofi.

Authors :
Taylor, Nick Paul
Source :
FierceBiotech; 12/13/2024, pN.PAG-N.PAG, 1p
Publication Year :
2024

Abstract

Dietmar Berger's appointment reunites Gilead CEO Daniel O'Day with a key member of the oncology team from his time at Roche. [ABSTRACT FROM AUTHOR]

Details

Language :
English
Database :
Complementary Index
Journal :
FierceBiotech
Publication Type :
Periodical
Accession number :
181652801